 | • レポートコード：20QY06-00905 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インフルエンザワクチンのグローバル市場について種類別（全ウイルスワクチン、スプリットウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン）、用途別（子供（6ヶ月〜3歳）、大人・3歳以上子供）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インフルエンザワクチン市場の概要 ・世界の主要地域別インフルエンザワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインフルエンザワクチン市場規模2015-2026：種類別（全ウイルスワクチン、スプリットウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン） ・世界のインフルエンザワクチン市場規模2015-2026：用途別（子供（6ヶ月〜3歳）、大人・3歳以上子供） ・インフルエンザワクチンの北米市場規模2015-2020 ・インフルエンザワクチンのヨーロッパ市場規模2015-2020 ・インフルエンザワクチンの中国市場規模2015-2020 ・インフルエンザワクチンの日本市場規模2015-2020 ・インフルエンザワクチンの東南アジア市場規模2015-2020 ・インフルエンザワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL、GSK、Sanofi Pasteur、Mylan、AstraZeneca、Pfizer、Johnson & Johnson） ・インフルエンザワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インフルエンザワクチンの市場動向・機会・課題 ・調査の結論 |
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines In 2018 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion In 2018 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% In 2018. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
Market Analysis and Insights: Global Influenza Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Influenza Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Influenza Vaccine industry.
Based on our recent survey, we have several different scenarios about the Influenza Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Influenza Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Influenza Vaccine Scope and Market Size
The global Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Influenza Vaccine market is segmented into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Segment by Application, the Influenza Vaccine market is segmented into
For Children (6 months to 3 years)
For Adults and Children over 3 years
The Influenza Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Influenza Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza Vaccine Market Share Analysis
Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Vaccine business, the date to enter into the Influenza Vaccine market, Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
…
1 Influenza Vaccine Market Overview
1.1 Influenza Vaccine Product Scope
1.2 Influenza Vaccine Segment by Type
1.2.1 Global Influenza Vaccine Sales by Type (2020-2026)
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Influenza Vaccine Segment by Application
1.3.1 Global Influenza Vaccine Sales Comparison by Application (2020-2026)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Influenza Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Influenza Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Influenza Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Influenza Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Influenza Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Influenza Vaccine Industry
1.5.1.1 Influenza Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Influenza Vaccine Players to Combat Covid-19 Impact
2 Influenza Vaccine Estimate and Forecast by Region
2.1 Global Influenza Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Influenza Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Influenza Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Influenza Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Influenza Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Influenza Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Influenza Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Influenza Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Influenza Vaccine Estimates and Projections (2015-2026)
2.4.3 China Influenza Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Influenza Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Influenza Vaccine Estimates and Projections (2015-2026)
2.4.6 India Influenza Vaccine Estimates and Projections (2015-2026)
3 Global Influenza Vaccine Competition Landscape by Players
3.1 Global Top Influenza Vaccine Players by Sales (2015-2020)
3.2 Global Top Influenza Vaccine Players by Revenue (2015-2020)
3.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2019)
3.4 Global Influenza Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Influenza Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Influenza Vaccine Players (Opinion Leaders)
4 Global Influenza Vaccine Market Size by Type
4.1 Global Influenza Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Influenza Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Influenza Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Influenza Vaccine Price by Type (2014-2020)
4.2 Global Influenza Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Influenza Vaccine Price Forecast by Type (2021-2026)
5 Global Influenza Vaccine Market Size by Application
5.1 Global Influenza Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Influenza Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Influenza Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Influenza Vaccine Price by Application (2015-2020)
5.2 Global Influenza Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Vaccine Price Forecast by Application (2021-2026)
3 North America Influenza Vaccine Market Facts & Figures
3.2 North America Influenza Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Influenza Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Influenza Vaccine Sales Market Share by Application (2015-2020)
4 Europe Influenza Vaccine Market Facts & Figures
4.2 Europe Influenza Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Influenza Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Influenza Vaccine Sales Market Share by Application (2015-2020)
5 China Influenza Vaccine Market Facts & Figures
5.2 China Influenza Vaccine Sales Market Share by Company (2015-2020)
5.3 China Influenza Vaccine Sales Market Share by Type (2015-2020)
5.4 China Influenza Vaccine Sales Market Share by Application (2015-2020)
6 Japan Influenza Vaccine Market Facts & Figures
6.2 Japan Influenza Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Influenza Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Influenza Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Influenza Vaccine Market Facts & Figures
7.2 Southeast Asia Influenza Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Influenza Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Influenza Vaccine Sales Market Share by Application (2015-2020)
8 India Influenza Vaccine Market Facts & Figures
8.2 India Influenza Vaccine Sales Market Share by Company (2015-2020)
8.3 India Influenza Vaccine Sales Market Share by Type (2015-2020)
8.4 India Influenza Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Influenza Vaccine Business
12.1 CSL
12.1.1 CSL Influenza Vaccine Corporation Information
12.1.2 CSL Influenza Vaccine Business Overview and Total Revenue
12.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Influenza Vaccine Products Offered
12.1.5 CSL Recent Development
12.2 GSK
12.2.1 GSK Influenza Vaccine Corporation Information
12.2.2 GSK Influenza Vaccine Business Overview and Total Revenue
12.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Influenza Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Influenza Vaccine Corporation Information
12.3.2 Sanofi Pasteur Influenza Vaccine Business Overview and Total Revenue
12.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Pasteur Influenza Vaccine Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Mylan
12.4.1 Mylan Influenza Vaccine Corporation Information
12.4.2 Mylan Influenza Vaccine Business Overview and Total Revenue
12.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Influenza Vaccine Products Offered
12.4.5 Mylan Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Influenza Vaccine Corporation Information
12.5.2 AstraZeneca Influenza Vaccine Business Overview and Total Revenue
12.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AstraZeneca Influenza Vaccine Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Pfizer
12.6.1 Pfizer Influenza Vaccine Corporation Information
12.6.2 Pfizer Influenza Vaccine Business Overview and Total Revenue
12.6.3 Pfizer Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Influenza Vaccine Products Offered
12.6.5 Pfizer Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Influenza Vaccine Corporation Information
12.7.2 Johnson & Johnson Influenza Vaccine Business Overview and Total Revenue
12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Johnson & Johnson Influenza Vaccine Products Offered
12.7.5 Johnson & Johnson Recent Development
…
13 Influenza Vaccine Manufacturing Cost Analysis
13.1 Influenza Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Influenza Vaccine
13.4 Influenza Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Influenza Vaccine Distributors List
14.3 Influenza Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Influenza Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Influenza Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Influenza Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Influenza Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Influenza Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Influenza Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Influenza Vaccine Sales (K Doses) by Region (2015-2020)
Table 10. Global Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Influenza Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Influenza Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Influenza Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Influenza Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Influenza Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Influenza Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Influenza Vaccine (K Doses) of Key Companies (2015-2020)
Table 18. Global Influenza Vaccine Sales Share by Company (2015-2020)
Table 19. Global Influenza Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Influenza Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2019)
Table 22. Global Influenza Vaccine Average Price (USD/Doses) of Key Company (2015-2020)
Table 23. Manufacturers Influenza Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Influenza Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Influenza Vaccine Players
Table 27. Global Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 28. Global Influenza Vaccine Sales Share by Type (2015-2020)
Table 29. Global Influenza Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Influenza Vaccine Price (K Doses) by Type (2015-2020)
Table 31. Global Influenza Vaccine Sales Share by Type (2021-2026)
Table 32. Global Influenza Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Influenza Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Influenza Vaccine Price (K Doses) by Type (2021-2026)
Table 35. Global Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 36. Global Influenza Vaccine Sales Share by Application (2015-2020)
Table 37. Global Influenza Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Influenza Vaccine Price (K Doses) by Application (2015-2020)
Table 39. Global Influenza Vaccine Sales (K Doses) by Application (2021-2026)
Table 40. Global Influenza Vaccine Sales Share by Application (2021-2026)
Table 41. Global Influenza Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Influenza Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Influenza Vaccine Price (K Doses) by Application (2021-2026)
Table 44. United States Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 45. United States Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 47. United States Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. United States Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 57. China Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 59. China Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 61. China Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 75. India Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 77. India Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 79. India Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 83. CSL Influenza Vaccine Product
Table 84. CSL Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 88. GSK Influenza Vaccine Product
Table 89. GSK Recent Development
Table 90. Sanofi Pasteur Corporation Information
Table 91. Sanofi Pasteur Description and Business Overview
Table 92. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 93. Sanofi Pasteur Influenza Vaccine Product
Table 94. Sanofi Pasteur Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 98. Mylan Influenza Vaccine Product
Table 99. Mylan Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 103. AstraZeneca Influenza Vaccine Product
Table 104. AstraZeneca Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 108. Pfizer Influenza Vaccine Product
Table 109. Pfizer Recent Development
Table . Johnson & Johnson Corporation Information
Table . Johnson & Johnson Description and Business Overview
Table . Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table . Johnson & Johnson Influenza Vaccine Product
Table . Johnson & Johnson Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Influenza Vaccine Distributors List
Table 118. Influenza Vaccine Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Influenza Vaccine Market Share by Application in 2020 & 2026
Figure 6. For Children (6 months to 3 years) Examples
Figure 7. For Adults and Children over 3 years Examples
Figure 8. Global Influenza Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Influenza Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Influenza Vaccine Price Trends Growth Rate (2015-2026) (USD/Doses)
Figure 11. Global Influenza Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Influenza Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Influenza Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Influenza Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Influenza Vaccine Players Market Share by Revenue in Influenza Vaccine 2015 & 2019
Figure 26. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Influenza Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Influenza Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Influenza Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Influenza Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Influenza Vaccine Sales Market Share by Type in 2019
Figure 32. United States Influenza Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Influenza Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Influenza Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Influenza Vaccine Sales Market Share by Application in 2019
Figure 36. China Influenza Vaccine Sales Market Share by Company in 2019
Figure 37. China Influenza Vaccine Sales Market Share by Type in 2019
Figure 38. China Influenza Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Influenza Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Influenza Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Influenza Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Influenza Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Influenza Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Influenza Vaccine Sales Market Share by Application in 2019
Figure 45. India Influenza Vaccine Sales Market Share by Company in 2019
Figure 46. India Influenza Vaccine Sales Market Share by Type in 2019
Figure 47. India Influenza Vaccine Sales Market Share by Application in 2019
Figure 48. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Influenza Vaccine
Figure 57. Manufacturing Process Analysis of Influenza Vaccine
Figure 58. Influenza Vaccine Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
イヌインフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Canine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canine Influenza Vac…- 馬インフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Equine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Equine Influenza Vac…
- 鳥インフルエンザワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Avian Influenza Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- インフルエンザ薬＆ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Influenza Drugs and Vaccines Market The global Influenza Drugs and Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Influenza Drugs and Vaccines Scope and Mark…
- エボラウイルスワクチンの世界市場レポート2020 Market Analysis and Insights: Global Ebola Virus Vaccine Market The global Ebola Virus Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Ebola Virus Vaccine Scope and Market Size The global Ebola Vi…